Primer registro del pulpo 'Octopus' selene Voss, 1971 (Cephalopoda: Octopoda) en aguas peruanas con comentarios de su distribución geográfica

En el presente trabajo se registra de primera vez 'Octopus' selene en aguas peruanas y se amplía su rango de distribución sur hasta Cabo Blanco, Piura, Perú. Cuatro ejemplares machos de 34 - 50 mm LM fueron capturados entre los 03°34'S y 04°06'S a profundidades de 109 a 150 m. Se proporciona una breve descripción, con observaciones taxonómicas y comentarios sobre su distribución geográfica de esta especie.

In this paper, 'Octopus' selene is first registered in Peruvian waters and its distribution range extends south to Cabo Blanco, Piura, Peru. Four male specimens of 34 - 50 mm ML were captured between 03°34'S and 04°06'S at depths of 109 - 150 m. A brief description is provided, with taxonomic observations and comments on its geographical distribution of this species.

Anti-cyclic citrullinated peptide antibodies, other common autoantibodies, and smoking as risk factors for lymphoma in patients with rheumatoid arthritis.

OBJECTIVES: Patients with rheumatoid arthritis (RA) are at increased risk of lymphoma. There is no biomarker to indicate future lymphoma risk in RA and it is not known whether factors associated with an increased risk of RA also confer an increased risk of lymphoma. We investigated whether anti-cyclic citrullinated peptide (CCP) antibodies, other autoantibodies, and smoking, are associated with lymphoma development in RA. METHOD: From two population-based case-control studies, the Scandinavian Lymphoma Etiology (SCALE) study and the Epidemiological Investigation of Rheumatoid Arthritis (EIRA) I study, we identified lymphoma cases with a validated RA diagnosis (n = 50), to whom we matched study participants with RA but no lymphoma (n = 261), lymphoma but no RA (n = 257), and neither RA nor lymphoma (n = 233). Lymphomas were classified according to the WHO classification. Blood samples were analysed for immunoglobulin G (IgG), IgM, and IgA isotypes and IgG1-4 subclasses of anti-CCP antibodies and for 15 antinuclear antibody (ANA)-associated specific autoantibodies. Relative risks were estimated as crude and adjusted odds ratios (adjOR) with 95% confidence intervals (CIs) using logistic regression. RESULTS: We found no association between anti-CCP IgG ≥ 25 units/mL (adjOR 1.4, 95% CI 0.7-2.7), anti-CCP IgG ≥ 500 units/mL (adjOR 1.4, 95% CI 0.7-3.0), anti-CCP Ig of other isotypes, other autoantibodies (adjOR any vs none 0.6, 95% CI 0.3-1.2), or cigarette smoking (adjOR ever vs never 1.1, 95% CI 0.5-2.2) and lymphoma risk among patients with RA. CONCLUSION: In this study, neither anti-CCP antibodies (IgG, IgG1-4, IgM, or IgA), nor other common autoantibodies, nor smoking predicted lymphoma risk in RA.

Primer registro del pulpo de profundidad Muusoctopus longibrachus (Cephalopoda: Octopoda) para el mar peruano

El pulpo de profundidad Muusoctopus longibrachus (Ibañez et al. 2006) se registra por primera vez en el mar peruano. Dos ejemplares machos fueron capturados a 852 - 875 m de profundidad entre los 05°08S y 09°18S. Esta especie se le conocía sólo para Chile, en el presente trabajo se amplia su distribución norte hasta Perú.

The octopus deep-sea Muusoctopus longibrachus (Ibañez et al. 2006) is recorded for the first time in the Peruvian sea. Two male specimens were caught at 852 - 875 m depth between 05°08'S and 09°18'S. This species was known only from Chile, in the present study extends its distribution north to Peru.

A new dicyemid from Octopus hubbsorum (Mollusca:Cephalopoda:Octopoda).

A new species of dicyemid mesozoan is described from Octopus hubbsorum Berry, 1953, collected in the south of Bahia de La Paz, Baja California Sur, México. Dicyema guaycurense n. sp. is a medium-size species that reaches about 1,600 µm in length. It occurs in folds of the renal appendages. The vermiform stages are characterized as having 22 peripheral cells, a conical calotte, and an axial cell that extends to the base of the propolar cells. Infusoriform embryos consist of 39 cells; 1 nucleus is present in each urn cell and the refringent bodies are solid. This is the first of a dicyemid species from a host collected in the Gulf of California.

Aggregata bathytherma sp. nov. (Apicomplexa:Aggregatidae), a new coccidian parasite associated with a deep-sea hydrothermal vent octopus.

Aggregata bathytherma sp. nov. is described from the digestive tract of Vulcanoctopus hydrothermalis, a deep-sea octopus recently discovered associated with hydrothermal vents in the northeast Pacific Ocean. Oocysts typically are spherical in shape, sometimes irregular, 163 to 356 microm in length, and 219 to 313 microm in width. Each oocyst contains from 50 to over 200 sporocysts. Sporocysts measure 27 to 32 microm in longest diameter. The cyst wall is smooth and 1 microm thick. Each sporocyst typically contains 14 to 17 sporozoites, 49 microm in length. Histological lesions associated with the presence of A. bathytherma include rupture of the basal membrane and detachment of the epithelial cells. In heavily infected areas, most of the tissue of the host digestive tract is replaced by parasites. A. bathytherma is the first Aggregata species described from a host that lives in association with hydrothermal vents, and the third species of Aggregata from eastern North Pacific waters.

Aggregata andresi n. sp. (Apicomplexa: Aggregatidae) from the ommastrephid squid Martialia hyadesi in the SW Atlantic Ocean and some general remarks on Aggregata spp. in cephalopod hosts.

A new species of coccidian, Aggregata andresi, is described from the digestive tract of the flying squid Martialia hyadesi, an ommastrephid squid that lives in cold subantarctic waters in the Southwest Atlantic. Gamogonic and sporogonic stages were observed in the digestive tract of 96.5% studied hosts. Oocysts were ovoid to subspheroid in shape, 170-590 microm in length and 200-530 microm in width. Each oocyst contained approximately 45,000 sporocysts. Sporocysts measured 9.5-10 microm in length and 8-8.5 microm in width. The surface of the sporocyst wall was smooth and the cyst wall thick. Each sporocyst contained three sporozoites measuring 16-20 microm in length and 2-2.5 microm width. A. andresi is the second species of Aggregata to be reported from a nerito-oceanic cephalopod host.

Intravascular lymphoma: magnetic resonance imaging correlates of disease dynamics within the central nervous system.

BACKGROUND: Intravascular lymphoma (IVL) is a rare non-Hodgkin's lymphoma with relative predilection for the central nervous system. In the absence of extraneural manifestations, the disease is not recognised until autopsy in the majority of cases underlining the need for new clinical markers. METHODS: This is a retrospective series of five patients with IVL seen at a single institution over three years. An advanced magnetic resonance imaging (MRI) protocol was performed at various time points prior to diagnosis and during treatment. RESULTS: MRI revealed multiple lesions scattered throughout the cerebral hemispheres; the brainstem, cerebellum, and spinal cord were less frequently involved. On initial presentation, hyperintense lesions were seen on diffusion weighted images suggestive of ischaemia in three of four patients in whom the images were obtained at that time point. In four patients lesions were also identifiable as hyperintense areas on fluid attenuated inversion recovery (FLAIR) sequences. Initial contrast enhancement was encountered in three cases. Diffusion weighted imaging lesions either vanished or followed the typical pattern of an ischaemic small vessel stroke with evolution of abnormal FLAIR signal followed by enhancement with gadolinium in the subacute stage and tissue loss in the chronic stage. Diffusion weighted imaging and FLAIR abnormalities proved to be partially reversible, correlating with the response to chemotherapy. CONCLUSION: We provide the first detailed description of the dynamic pattern of diffusion weighted MRI in IVL. These patterns in combination with systemic findings may facilitate early diagnosis and serve as a new tool to monitor treatment response.

Cell number and cellular composition in infusoriform larvae of dicyemid mesozoans (Phylum Dicyemida).

Cell numbers and cellular composition were examined in infusoriform larvae of 44 species of dicyemid mesozoans belonging to 6 genera; Conocyema, Dicyema, Dicyemennea, Dicyemodeca, Microcyema, and Pseudicyema. In addition, literature on infusoriform larvae of another 20 species was reviewed. Infusoriform larvae consist of a constant cell number which is species-specific. Small interspecific variations are found in total cell numbers, 35, 37, 39, 41 and 42. The most frequent cell number encountered in infusoriform larvae studied is either 37 or 39. Infusoriform larvae with 35 cells are found in three genera. Infusoriform larvae with 37 cells are found in four genera. Infusoriform larvae with 39 cells are found in four genera. Most differences in total cell numbers are due to the absence or presence of particular ventral cells. In all infusoriform larvae, the lateral, dorsal and caudal areas are cell constant, whereas in the apical and ventral areas a distinct and variable configuration of cells are present. In cellular composition, a total of 29 cells (15 cell types) were recognized in all infusoriform larvae examined. Additional cell types are characteristic of a relatively few species. Even in infusoriform larvae with the same total cell numbers, cellular composition varies by species. Thus, there are 7 variations of cellular composition in infusoriform larvae with 37 cells. Differences in larval cell numbers and types do not warrant traditional generic separation of dicyemids.

Development of a novel non-human primate model for preclinical gene vector safety studies. Determining the effects of intracerebral HSV-1 inoculation in the common marmoset: a comparative study.

The owl monkey (Aotus trivirgatus) has served as the standard non-human primate model of herpes simplex virus-1 (HSV-1) infection because it is highly susceptible to HSV-1 encephalitis. Owl monkeys, however, are expensive, difficult to obtain, and difficult to maintain in captivity, thus greatly hampering the efficiency of preclinical gene therapy trials for brain tumors using HSV-1-based vectors. We have therefore compared the susceptibility of the common marmoset (Callithrix jacchus) with the owl monkey in a model of intracerebral inoculation of wildtype HSV-1 F-strain at increasing titers. The common marmosets consistently succumbed earlier to viral encephalitis than the owl monkeys. The histological evaluation of the common marmoset revealed extensive HSV-1 infection with a concomitant yet less marked inflammatory response compared to the owl monkeys. PCR for HSV-1 demonstrated a similar extra-CNS shedding route in both experimental models. Our findings show that the common marmoset is at least as susceptible to intracerebral HSV-infection as the owl monkey and that it can therefore serve as a valid and reliable experimental model for the important preclinical safety tests of HSV-based therapeutic viral vector constructs in the brain.

Phylogenetic relationships among cirrate octopods (Mollusca: Cephalopoda) resolved using mitochondrial 16S ribosomal DNA sequences.

PHYLOGENETIC RELATIONSHIPS AMONG THE CIRRATE OCTOPODS (MOLLUSCA: Cephalopoda) were investigated using partial sequences of the 16S rRNA mitochondrial gene. The derived phylogeny supports the traditional separation of cirrate families based on web form. Genera with a single web (Opisthoteuthis, Grimpoteuthis, Luteuthis, and Cirroctopus) are clearly distinct from those with an intermediate or secondary web (Cirroteuthis, Cirrothauma, and Stauroteuthis). The cirrates with a single web are separated into three groups. The first group is represented by Opisthoteuthis species, the second by Grimpoteuthis and Luteuthis, and the third by members of the genus Cirroctopus. There is no support for the isolation of Luteuthis in a separate family (Luteuthidae). There is, however, evidence of two groupings within the genus Opisthoteuthis. The data suggest the following revisions in the systematic classification of the cirrates: (1) Cirrothauma, Cirroteuthis, and Stauroteuthis be united in the Cirroteuthidae; (2) Grimpoteuthis and Luteuthis be placed in the Grimpoteuthidae; (3) Opisthoteuthis in the Opisthoteuthidae, and; (4) Cirroctopus be considered sufficiently distinct from both Opisthoteuthidae and Grimpoteuthidae to warrant placement in a new family.

Dicyemennea canadensis n. sp. (phylum Dicyemida) from Bathypolypus arcticus (Mollusca: Cephalopoda: Octopoda).

Dicyemennea canadensis n. sp. is described from a bathyal octopus collected off Canada in the Bay of Fundy. The dicyemid is a small species that rarely exceeds 600 microm in length. The vermiform stages are further characterized as having 17-23 peripheral cells, a conical-shaped calotte, an axial cell that extends to the base of the propoplar cells, and no abortive axial cells. Infusoriform embryos consist of 37 cells. There is 1 nucleus in each urn cell, and refringent bodies are absent. This is the first dicyemid to be described from the cephalopod Bathypolypus arcticus (Prosch. 1847), and the first dicyemid reported from Canada. In addition, it is the first species of Dicyemennea from the northwestern Atlantic Ocean to be described.

Dicyema shorti n. sp. (phylum Dicyemida) from Octopus burryi (Mollusca: Cephalopoda: Octopodidae) in the Gulf of Mexico.

Nematogens and vermiform embryos of a new species of Dicyema are described from an octopus collected off Veracruz, Mexico. Dicyema shorti n. sp. is a small dicyemid species that rarely exceeds 500 microm in length. It is further characterized by the presence of 18 peripheral cells in the vermiform stages, a conical-shape calotte, and an axial cell that extends to the base of the propolar cells. Other stages in the life cycle of the parasite are not known. This is the first dicyemid to be described from Octopus burryi Voss. 1950, and also from both the southern Gulf of Mexico and the country of Mexico.

New species of Dicyemennea (phylum: Dicyemida) in deep-water Graneledone (Mollusca: Cephalopoda: Octopoda) from the Antarctic.

Two new species of dicyemids are described from 2 species of deep benthic cephalopods, Graneledone antarctica and G. macrotyla, collected in the Southern Ocean south of the Antarctic Convergence. Dicyemennea bathybenthum n. sp. was found in G. antarctica. It is a medium-sized dicyemid whose length does not exceed 1,000 microm. The calotte is bluntly rounded or conical in small individuals, but the shape becomes discoidal in large individuals. Nematogens and vermiform embryos have 23 peripheral cells. An anterior abortive axial cell is present in vermiform embryos. Other stages in the life cycle were not observed. Dicyemennea dorycephalum n. sp. was found in G. macrotyla. It is a medium to large dicyemid that rarely exceeds 4,000 microm. The calotte is distinctly pointed, similar in shape to a spearhead. Vermiform stages typically have either 25 or 27 peripheral cells. An anterior abortive axial cell is present in vermiform embryos. Infusoriform embryos have 37 cells, the refringent bodies are solid in composition, and 2 nuclei are present in each urn cell.

Developmental patterns and cell lineages of vermiform embryos in dicyemid mesozoans.

Patterns of cell division and cell lineages of the vermiform embryos of dicyemid mesozoans were studied in four species belonging to four genera: Conocyema polymorpha, Dicyema apalachiensis, Microcyema vespa, and Pseudicyema nakaoi. During early development, the following common features were apparent: (1) the first cell division produces prospective cells that generate the anterior peripheral region of the embryo; (2) the second cell division produces prospective cells that generate the posterior peripheral region plus the internal cells of the embryo; (3) in the lineage of prospective internal cells, several divisions ultimately result in cell death of one of the daughter cells. Early developmental processes are almost identical in the vermiform embryos of all four dicyemid genera. The cell lineages appear to be invariant among embryos and are highly conserved among species. Species-specific differences appear during later stages of embryogenesis. The number of terminal divisions determines variations in peripheral cell numbers among genera and species. Thus, the numbers of peripheral cells are fixed and hence species-specific.

Clinical relevance of consolidation radiotherapy and other main therapeutic issues in primary central nervous system lymphomas treated with upfront high-dose methotrexate.

PURPOSE: To evaluate the optimal dose of methotrexate (MTX) and the efficacy of other drugs, intrathecal chemotherapy (CHT), and radiotherapy (RT) in primary brain lymphomas. METHODS AND MATERIALS: Two hundred eighty-eight immunocompetent patients with histologically documented, previously untreated primary brain lymphomas, receiving CHT containing high-dose MTX (> or =1 g/m(2)) with or without RT were selected from 19 prospective series. The impact on survival of the MTX dose (<3 g/m(2) vs.> or =3 g/m(2)), the main drugs, intrathecal CHT, and combination CHT (mono-CHT vs. poly-CHT) was assessed, according to the intention-to-treat principle. The role of post-CHT irradiation (immediate vs. delayed RT) was evaluated in 119 patients with a complete response to CHT. The whole brain and tumor bed dose (<40 Gy vs. > or =40 Gy) was assessed in 70 irradiated complete responders. RESULTS: No difference in overall survival (OS) was detected between mono-CHT and combination CHT (p = 0.38). MTX > or =3 g/m(2) (p = 0.04), thiotepa (p = 0.03), and intrathecal CHT (p = 0.03) improved the OS, and nitrosoureas (p = 0.01) correlated with a worse survival. In multivariate analysis, limited to patients receiving MTX > or =3 g/m(2), only the addition of cytarabine improved the OS; nitrosoureas reduced MTX efficacy. Of the 119 complete responders, 70 received immediate RT. A RT dose of > or =40 Gy to the whole brain or tumor bed did not improve OS. The 3-year OS was similar between the immediate and delayed RT groups. In multivariate analysis, RT delay had no negative impact on survival. CONCLUSIONS: MTX > or =3 g/m(2) seems to improve survival in primary brain lymphoma patients. The efficacy of additional drugs, except for cytarabine, remains unproved. Randomized trials are needed to confirm that RT withdrawal yields no detrimental effect in complete responders.

Dose-escalation with proton/photon irradiation for Daumas-Duport lower-grade glioma: results of an institutional phase I/II trial.

PURPOSE: The role of dose escalation with proton/photon radiotherapy in lower-grade gliomas was assessed in a prospective Phase I/II trial. We report the results in terms of local control, toxicity, and survival. MATERIALS AND METHODS: Twenty patients with Grade 2/4 (n = 7) and Grade 3/4 (n = 13) gliomas according to the Daumas-Duport classification were treated on a prospective institutional protocol at Massachusetts General Hospital/Harvard Cyclotron Laboratory between 1993 and 1996. Doses prescribed to the target volumes were 68.2 cobalt Gray equivalent (CGE, 1 proton Gray = 1.1 CGE) to gross tumor in Grade 2 lesions and 79.7 CGE in Grade 3 lesions. Fractionation was conventional, with 1.8 to 1.92 CGE once per day. Eligibility criteria included age between 18 and 70 years, biopsy-proven Daumas-Duport Grade 2/4 or 3/4 malignant glioma, Karnofsky performance score of 70 or greater, and supratentorial tumor. Median age of the patient population at diagnosis was 35.9 years (range 19-49). Ten tumors were mixed gliomas, one an oligodendroglioma. RESULTS: Five patients underwent biopsy, 12 a subtotal resection, and 3 a gross total resection. Median interval from surgery to first radiation treatment was 2.9 months. Actuarial 5-year survival rate for Grade 2 lesions was 71% as calculated from diagnosis (median survival not yet reached); actuarial 5-year survival for Grade 3 lesions was 23% (median 29 months). Median follow-up is 61 months and 55 months for 4 patients alive with Grade 2 and 3 patients alive with Grade 3 lesions, respectively. Three patients with Grade 2 lesions died from tumor recurrence, whereas 2 of the 4 survivors have evidence of radiation necrosis. Eight of 10 patients who have died with Grade 3 lesions died from tumor recurrence, 1 from pulmonary embolus, and 1 most likely from radiation necrosis. One of 3 survivors in this group has evidence of radiation necrosis. CONCLUSION: Tumor recurrence was neither prevented nor noticeably delayed in our patients relative to published series on photon irradiation. Dose escalation using this fractionation scheme and total dose delivered failed to improve outcome for patients with Grade 2 and 3 gliomas.

Intraneoplastic polymer-based delivery of cyclophosphamide for intratumoral bioconversion by a replicating oncolytic viral vector.

rRp450 is an oncolytic herpesvirus that expresses the CYP2B1 cDNA, responsible for bioconverting cyclophosphamide (CPA) into the active metabolites 4-hydroxyCPA/aldophosphamide (AP). However, formal proof of prodrug activation is lacking. We report that activation of CPA in cells infected with rRp450 generates a time-dependent increase of diffusible 4-hydroxyCPA/AP. For in vivo applications, a CPA-impregnated polymer was implanted into human tumor xenografts inoculated with rRp450. The area under the curve for 4-hydroxyCPA/AP was 806 microg/g of tumor tissue/h when CPA was administered via intraneoplastic polymer and 3 microg/g of tumor tissue/h when CPA was administered i.p. Therefore, (a) a lytic virus expressing a "suicide" gene can activate a prodrug; and (b) within rRp450-infected tumor, more prolonged and higher concentrations of activated metabolites are generated by intraneoplastic compared with systemic administration of prodrug.